A gathering of specialists from Johns Hopkins School of Medicine driven by Griffiths led an investigation to evaluate the prompt and long haul mental impacts of the psilocybin experience, utilizing an altered form of the enchanted experience poll and a thorough twofold visually impaired strategy. At the point when gotten some information about the comparability of his work with Leary's, Griffiths clarified the distinction: "We are directing thorough, methodical research with psilocybin under painstakingly observed conditions, a course which Dr. Leary surrendered in the mid 1960s." The National Institute of Drug Abuse-financed ponder, distributed in 2006, has been lauded by specialists for the soundness of its trial structure. In the investigation, 36 volunteers without related knowledge with drugs were given psilocybin and methylphenidate (Ritalin) in independent sessions; the methylphenidate sessions filled in as a control and psychoactive fake treatment. The level of otherworldly experience was estimated utilizing a survey created by Ralph W. Hood; 61% of subjects detailed a "total enchanted encounter" after their psilocybin session, while just 13% revealed such a result after their involvement with methylphenidate. Two months in the wake of taking psilocybin, 79% of the members announced modestly to significantly expanded life fulfillment and feeling of prosperity. About 36% of members additionally had a solid to extraordinary "experience of dread" or dysphoria (i.e., an "awful excursion") sooner or later amid the psilocybin session (which was not detailed by any subject amid the methylphenidate session); around 33% of these (13% of the aggregate) announced that this dysphoria commanded the whole session. These negative impacts were accounted for to be effectively overseen by the analysts and did not have an enduring negative impact regarding the matter's feeling of prosperity. 